Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-18

Clinical Trial Update: Neurocognitive Impact of Hypoglycemia in Type 1 Diabetes

View source ↗

Summary

A completed clinical trial evaluating the neurocognitive impact of hypoglycemia in individuals with Type 1 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Type 1 Diabetes Mellitis | Status: COMPLETED